Pulmonx Cash Flow from Financial Activities 2019-2025 | LUNG
Pulmonx cash flow from financial activities from 2019 to 2025. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
| Pulmonx Annual Cash Flow Financial (Millions of US $) |
|
|---|---|
| 2024 | $1 |
| 2023 | $21 |
| 2022 | $2 |
| 2021 | $4 |
| 2020 | $235 |
| 2019 | $46 |
| 2018 | $12 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.117B | $0.084B |
| Pulmonx Corporation is a medical technology company. It designs, develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of chronic obstructive pulmonary diseases. Pulmonx Corporation is based in Redwood City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.159B | 58.73 |
| Doximity (DOCS) | United States | $11.724B | 54.28 |
| Hims & Hers Health (HIMS) | United States | $11.606B | 120.58 |
| Tempus AI (TEM) | United States | $10.382B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.760B | 58.76 |
| Hinge Health (HNGE) | United States | $3.663B | 0.00 |
| Privia Health (PRVA) | United States | $2.509B | 171.50 |
| Enovis (ENOV) | United States | $1.745B | 9.73 |
| Phreesia (PHR) | United States | $1.609B | 0.00 |
| Schrodinger (SDGR) | United States | $1.559B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| 10x Genomics (TXG) | United States | $1.523B | 0.00 |
| Azenta (AZTA) | United States | $1.469B | 68.25 |
| Evolent Health (EVH) | United States | $1.343B | 114.40 |
| Omnicell (OMCL) | United States | $1.301B | 22.96 |
| Claritev (CTEV) | United States | $0.725B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.549B | 0.00 |
| Veradigm (MDRX) | United States | $0.499B | 0.00 |
| Standard BioTools (LAB) | United States | $0.471B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.443B | 0.00 |
| Talkspace (TALK) | United States | $0.416B | 124.25 |
| TruBridge (TBRG) | United States | $0.326B | 722.33 |
| Outset Medical (OM) | United States | $0.321B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.271B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.188B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| American Well (AMWL) | United States | $0.129B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.121B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.87 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.088B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |